| Company Name: |
Bide Pharmatech Ltd.
|
| Tel: |
400-1647117 13681763483 |
| Email: |
product02@bidepharm.com |
| Products Intro: |
Product Name:2,4,7,9-Tetramethylbenzo[b][1,8]naphthyridin-5-amine CAS:309726-06-5 Purity:97% Package:25mg;50mg;100mg;250mg Remarks:BD177222
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
4008200310 15002144251 |
| Email: |
marketing@tsbiochem.com |
| Products Intro: |
Product Name:BMH-22 CAS:309726-06-5 Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500
|
Benzo[b][1,8]naphthyridin-5-amine, 2,4,7,9-tetramethyl- (9CI) manufacturers
- BMH-22
-
- $1520.00
-
2026-05-11
- CAS:309726-06-5
- Purity:
- Supply Ability: 10g
|
| | Benzo[b][1,8]naphthyridin-5-amine, 2,4,7,9-tetramethyl- (9CI) Basic information |
| Product Name: | Benzo[b][1,8]naphthyridin-5-amine, 2,4,7,9-tetramethyl- (9CI) | | Synonyms: | (2,4,7,9-tetramethylpyrido[2,3-b]quinolin-5-yl)amine;2,4,7,9-tetramethyl-5-pyrido[2,3-b]quinolinamine;2,4,7,9-tetramethylpyrido[2,3-b]quinolin-5-amine;Benzo[b][1,8]naphthyridin-5-amine, 2,4,7,9-tetramethyl- (9CI);BMH 22;BMH22;BMH-22 | | CAS: | 309726-06-5 | | MF: | C16H17N3 | | MW: | 251.33 | | EINECS: | | | Product Categories: | NAPHTHYRIDINE | | Mol File: | 309726-06-5.mol | ![Benzo[b][1,8]naphthyridin-5-amine, 2,4,7,9-tetramethyl- (9CI) Structure](CAS/GIF/309726-06-5.gif) |
| | Benzo[b][1,8]naphthyridin-5-amine, 2,4,7,9-tetramethyl- (9CI) Chemical Properties |
| | Benzo[b][1,8]naphthyridin-5-amine, 2,4,7,9-tetramethyl- (9CI) Usage And Synthesis |
| Description | BMH-22 is an inhibitor of RNA polymerase I. It acts by causing nucleolar stress and showing potent anticancer activity across many tumor types. | | Uses | BMH-22, a benzonaphthyridin, is a RNA polymerase I (Pol I) transcription inhibitor independent of p53 function. BMH-22 causes reorganization of nucleolar marker proteins consistent with segregation of the nucleolus. BMH-22 destabilizes RPA194 in a proteasome-dependent manner and inhibits nascent rRNA synthesis and expression of the 45S rRNA precursor. BMH-22 shows potent anticancer activity across many tumor types[1]. | | References | [1] RPA194, rRNA synthesis, 45S Rrna, anticancer
Karita Peltonen, et al. Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress. Mol Cancer Ther. 2014 Nov;13(11):2537-46. DOI:10.1158/1535-7163.MCT-14-0256 |
| | Benzo[b][1,8]naphthyridin-5-amine, 2,4,7,9-tetramethyl- (9CI) Preparation Products And Raw materials |
|